ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Fulcrum Therapeutics Inc

Fulcrum Therapeutics Inc (FULC)

3.47
-0.08
( -2.25% )
Updated: 12:22:02

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.88M1.18M685k295k1.18M871k080M
Operating Income -34.24M-24.36M-27.97M-27.94M-55.23M-27.99M-29.83M52.49M
Pre Tax Income -34.07M-23.74M-26.14M-24.78M-48.56M-24.76M-26.87M55.41M
Net Income -34.07M-23.74M-26.14M-24.78M-48.56M-24.76M-26.87M55.41M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -34.24M-24.36M-25.28M-24.78M-48.56M-24.76M-26.87M55.41M
EBITDA -33.56M-23.74M-27.38M-27.37M-54.1M-27.48M-29.36M52.87M
Year End December 30 2023 2017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0008.82M19.16M6.34M2.81M
Operating Income -22.99M-33.5M-84.22M-71.61M-81.05M-112.56M-110.66M
Pre Tax Income -22.96M-32.59M-82.68M-70.82M-80.85M-109.87M-97.34M
Net Income -25.37M-39.15M-89.81M-70.82M-80.85M-109.87M-97.34M
Preferred Dividends -2.41M-6.56M-7.13M0000
Basic Earnings Per Share (EPS) -3.728-3.522-3.964-2.535-1.99-2.704-1.574
EBIT -22.97M-33.11M-84.19M-71.61M-80.85M-109.87M-97.34M
EBITDA -22.28M-32.15M-82.16M-69.23M-78.54M-110.15M-108.49M